Program

PROGRAM

Program

08:00 – 10:30
ICOM CONTROVERSIES INMENINGIOMA

08:30 – 08:45 Welcome and Opening Professor Gelareh Zadeh and Professor Kate Drummond
Chairs Kate Drummond, James King
08:45 – 09:15 Gelareh Zadeh Update on molecular landscape of meningioma and its clinical significance
09:15 – 09:35 Farshad Nassiri Role of surgery and radiotherapy in higher grade meningioma in the molecular era
09:35 - 10:00 Jennifer Moliterno Surgery for skull base meningioma and the implication of genomics
10:00 - 10:20 Robert Smee Radiotherapy for skull base meningioma
10:20 – 10:30 Discussion  

10:30 – 11:00
Morning Tea
11:00 – 12:30
ICOM CONTROVERSIES IN MENINGIOMA

Chairs Jeff Brennan, Andrew Davidson
11:00 – 11:25 Michael Jenkinson Management of incidental meningiomas. What the evidence?
11:25 – 11:45 Andrew Morokoff Simpson's grade – is it still relevant?
11:45 – 12:05 Kate Drummond Quality of life in meningioma – more than walking and talking!
12:05 – 12:25 Richard Fessler Spinal meningioma – surgical indications and technique
12:25 – 12:30 Discussion

12:30 – 13:00
Lunch
13:00 – 15:00
ICOM CONTROVERSIES IN MENINGIOMA

Chairs James Dimou, Andrew Morokoff
13:00 – 13:20 David McArdle Advances in meningioma imaging
13:20 – 13:40 Gelareh Zadeh Liquid biopsy for meningioma, will it replace imaging?
13:40 – 14:00 Farshad Nassiri Meningiomas – when should we send for more testing?
14:00 – 14:20 Grace Kong Lu-DOTATE and theranostics for meningioma
14:20 – 14:35 Jordan Jones Meningioma in the elderly – what is the evidence?
14:35 – 14:55 Michael Jenkinson Multiple meningiomas – management priorities
14:55 – 15:00 Discussion

15:00 – 15:30
Afternoon Tea
15:30 – 16:30
ICOM TUMOUR BOARD

Chair Kate Drummond, Jordan Jones Discussants Farshad Nassiri, Gelareh Zadeh, Jennifer Moliterno, Michael Jenkinson, Robert Smee, Lynne Lucena
15:30 – 15:45 Heidi McAlpine Multiple meningiomas
15:45 – 16:00 Benjamin Hunn Spheno-orbital meningioma with severe proptosis
16:00 – 16:15 Lachlan Evans Recurrent meningioma and the patient brings commercial sequencing results
16:15 – 16:30 Alex Landry Grade 2 meningioma completely or incompletely resected

Program

08:00 – 10:30
CONTROVERSIES IN TUMOUR NEUROSURGERY

08:00 – 08:15 Welcome and Opening
Chairs Kate Drummond, Jordan Jones
08:15 – 08:45 Jim Rutka Disrupting technologies in tumour neurosurgery
08:45 – 09:05 Gelareh Zadeh IDH inhibitors - where will they fit on our glioma treatment paradigm
09:05 – 09:25 Kate Drummond We are wasting valuable time with clinical trials
09:25 – 09:45 Bernhard Meyer Resection of recurrent glioblastoma – is there a clinical benefit?
09:45 – 10:05 James Whittle Tumour treating fields –should Australian patients travel to the USA?
10:05 – 10:25 Jennifer Moliterno Brain tumour surgery in the frail and elderly – decision making
10:25 – 10:30 Discussion

10:30 – 11:00
Morning Tea
11:00 – 12:30
CONTROVERSIES IN SKULL BASE SURGERY

Chairs Nick Hall, Ellison Stephenson
11:00 – 11:25 James King Surgery for prolactinoma. Making a comeback?
11:25 – 11:45 Jennifer Moliterno Hormones in skull base meningiomas, what should we advise our patients?
11:45 – 12:05 Robert Smee Protons for skull base tumours – is the hype justified?
12:05 – 12:25 Michael Jenkinson Pineal cysts – the new tumour surgery and gift that keeps on giving
11:25 – 12:30 Discussion

12:30 - 13:15
Lunch
13:15 – 14:00
PETER PETTY MEMORIAL LECTURE
Stefan Vilsmeier “Caution: Data will make you lose your innocence”
14:00 – 15:30
CONTROVERSIES IN BRAIN METASTASIS NEUROSURGERY

Chairs Adrian Praeger, Hari Bandi
14:00 – 14:20 Bernhard Meyer Extent of resection is unimportant in metastasis surgery
14:20 – 14:40 Brindha Shivalingham En bloc removal is essential in metastasis surgery
14:40 – 15:00 Grant McArthur Neurosurgery is dead – radiation and targeted agents are all we need for metastasis
15:00 – 15:20 Michael Jenkinson What can we do about leptomeningeal disease?
15:20 - 15:30 Discussion

15:30 – 16:00
Afternoon Tea
16:00 – 18:00
WORKSHOP - NAVIGATED TMS AND FIBRE-TRACKING FOR RESECTION PLANNING

16:00 – 16:20 Bernhard Meyer, Peter Vajkoczy Overseas experience and utilization of nTMS and fibre-tracking at key reference sites
16:20 – 16:40 Mathew Gutman, Andrew Gogos Local experience and utilisation of nTMS and fibre-tracking
16:40 – 18:00 Hands On Workshop nTMS mapping live demonstration and fibre-tracking hands-on training

19:00
Conference Dinner

Program

08:30 – 10:30
CONTROVERSIES IN VASCULAR NEUROSURGERY

Chairs Alex Adamides, Vincent Ng
08:30 – 08:55 Peter Vajkoczy Brainstem cavernoma – what to do and when
08:55 – 09:20 Murat Gunel Monitoring patients with a family history of aneurysms. Do genes matter?
09:20– 09:40 Leon Lai Do small aneurysms bleed? When should we treat them?
09:40–10:00 Peter Vajkoczy Does vasospasm still matter (and should it be a therapeutic target)?
10:00 - 10:30 Case Discussion
10:00 – 10:15 Case 1 Hui Lee
10:15 – 10:30 Case 2 Tom O’Donohoe

10:30 – 11:00
Morning Tea
11:00 – 12:45
MY GREATEST DISASTER

Chairs Kate Drummond, Marguerite Harding
11:00 – 11:15 Richard Fessler
11:15– 11:30 Gelareh Zadeh
11:30 – 11:45 Michael Jenkinson
11:45 – 12:00 Peter Vajkoczy
12:00 – 12:15 Bernhard Meyer
12:15 – 12:30 Murat Gunel
12:30 – 12:45 Jennifer Moliterno
12:45 – 13:00 James Rutka

1300 – 1330
Lunch
13:30 – 15:00
CONTROVERSIES IN SPINALNEUROSURGERY

Chairs Mo Awad, Patrick Lo
13:30 – 13:55 Richard Fessler Endoscopic spine surgery – marketing tool or paradigm shift?
13:55 – 14:15 Peter Vajkoczy Cervical pedicle screws are now the standard of care for subaxial spine surgery
14:15– 14:35 Catherine Cartwright We should be imposing BMI limits for spine surgery to protect our patients
14:35– 15:00 Case Discussion
14:35 - 14:47 Case 1 Cecilia Huo
14:47 – 15:00 Case 2 Darius Tan

15:00 – 15:30
Afternoon Tea
15:30 – 17:30
CONTROVERSIES IN SPINAL NEUROSURGERY

Chairs Tanya Yuen, Bhadu Kavar
15:30–15:50 Richard Fessler Controversies in spine surgery - what spinal surgeons are doing wrong
15:50– 16:10 Jim Rutka The trouble with the spinal surgery literature
16:10– 16:30 Bernhard Meyer Injections and ablations for back pain. Voodoo?
16:30 - 16:50 Mitchell Hansen ALIF, OLIF, PLIF, TLIF, PTP, ATP, WTF-LIF- will it ever stop?
16:50– 17:10 Rana Dhillon At which JOA should we treat cervical myelopathy?
17:10– 17:30 Discussion and Close

17:30
CLOSE
Ready to join our event? Register now to secure your spot.
REGISTER
SO, WHAT DO YOU THINK?

JOIN OUR COMMUNITY

Reserve My Seat

Copyright © Controversies in Neurosurgery. All rights reserved.